In8bio Cash And Equivalents vs. Total Debt

INAB Stock  USD 0.30  0.01  3.23%   
Considering In8bio's profitability and operating efficiency indicators, In8bio Inc may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess In8bio's ability to earn profits and add value for shareholders. At present, In8bio's PTB Ratio is projected to decrease significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 1.74, whereas Book Value Per Share is forecasted to decline to 0.75.
For In8bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of In8bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well In8bio Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between In8bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of In8bio Inc over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.74)
Return On Assets
(0.78)
Return On Equity
(1.80)
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

In8bio Inc Total Debt vs. Cash And Equivalents Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining In8bio's current stock value. Our valuation model uses many indicators to compare In8bio value to that of its competitors to determine the firm's financial worth.
In8bio Inc is rated fifth overall in cash and equivalents category among its peers. It is rated second overall in total debt category among its peers making up about  0.19  of Total Debt per Cash And Equivalents. The ratio of Cash And Equivalents to Total Debt for In8bio Inc is roughly  5.26 . The current year's Total Debt To Capitalization is expected to grow to 0.06. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the In8bio's earnings, one of the primary drivers of an investment's value.

In8bio Total Debt vs. Cash And Equivalents

Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

In8bio

Cash

 = 

Bank Deposits

+

Liquidities

 = 
25.74 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

In8bio

Total Debt

 = 

Bonds

+

Notes

 = 
4.89 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

In8bio Total Debt vs Competition

In8bio Inc is rated second overall in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 219.49 Million. In8bio holds roughly 4.89 Million in total debt claiming about 2.23% of equities under Health Care industry.
Total debt  Valuation  Revenue  Capitalization  Workforce

In8bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in In8bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, In8bio will eventually generate negative long term returns. The profitability progress is the general direction of In8bio's change in net profit over the period of time. It can combine multiple indicators of In8bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-38 M-36.1 M
Operating Income-30.3 M-28.8 M
Net Loss-30 M-28.5 M
Income Before Tax-30 M-28.5 M
Total Other Income Expense Net379.5 K398.5 K
Net Loss-13.2 M-13.8 M
Net Loss-30 M-28.5 M
Income Tax Expense-32.8 M-31.2 M
Change To Netincome2.5 M2.7 M
Net Loss(1.00)(1.05)
Income Quality 0.78  1.03 
Net Income Per E B T 0.87  0.77 

In8bio Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on In8bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of In8bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the In8bio's important profitability drivers and their relationship over time.

Use In8bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if In8bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will appreciate offsetting losses from the drop in the long position's value.

In8bio Pair Trading

In8bio Inc Pair Trading Analysis

The ability to find closely correlated positions to In8bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace In8bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back In8bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling In8bio Inc to buy it.
The correlation of In8bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as In8bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if In8bio Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for In8bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your In8bio position

In addition to having In8bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Trading Thematic Idea Now

Trading
Trading Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Trading theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Trading Theme or any other thematic opportunities.
View All  Next Launch
When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:
Check out Risk vs Return Analysis.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
To fully project In8bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of In8bio Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include In8bio's income statement, its balance sheet, and the statement of cash flows.
Potential In8bio investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although In8bio investors may work on each financial statement separately, they are all related. The changes in In8bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on In8bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.